Founded in 2009 by regional stakeholders, EUROBIOMED is the Life Science cluster from Southern France. We gather more than 250 innovative biotech and medtech companies, as well as leading research institutes, hospitals and universities. We lead territorial initiatives and help our members businesses and research organisations to innovate, finance, develop and achieve their scientific and business objectives, to ultimately improve the treatment and the lives of patients.
Eurobiomed tops European rankings in all stages of innovation: education, basic, translational and clinical research, technological innovation centers, start-ups and industrial success stories. Some of Eurobiomed main assets are the number of people involved, but also the quality of the network and trust that is established between its members, which reinforces the interactions and facilitates collaborations.
Our missions:
- Develop the Life Sciences network activity in the South of France (Animation of the innovation community, matchmaking and networking between members, organisation of more than 25 scientific and business events each year, advocacy to third parties (public authorities, international stakeholders), etc. ).
- Structuring public-private R&D projects to get funded (Monitoring calls for projects, Identification of public and private partners, Support for project building and financing, Project follow-up until market access).
- Personalised support for life sciences companies growth (Corporate strategy, Fundraising, Business development and international markets, Regulatory compliance, Industrialisation and production, Acceleration programmes, Open innovation programmes, etc.).
Our business areas are new therapeutics, medical devices, diagnostics & Imaging and Digital Health.
Eurobiomed is the leader of the European Diagnostic Cluster Alliance and is the first immunology cluster in Europe.
